New: our own Hairmetry line. Every ingredient explained

Encyclopedia · pathway modulator

Rapamycin (sirolimus)

The longevity-world favourite is a hair paradox: one 2019 mouse study found it starts hair growth, while older and 2013 mouse work found it does not or even delays it, and mTOR-pathway cancer drugs can cause hair loss.

Prescription medicine, used off-label for hair Cost $$ Safety: serious

hair lossslow growth

What it is

Sirolimus is a prescription immunosuppressant (transplant, rare diseases) that inhibits mTOR. Any hair use is off-label and experimental. Prescription-only in the US, EU and UK.

How it works

mTORC1 activity changes with the hair cycle. Whether blocking it helps depends on the model: it can trigger autophagy, which is linked to entering the growth phase, but it can also slow cycling.

What the studies show

  • In mice, cyclosporin A and FK506 induced growth, but rapamycin did not and blocked their effect. Iwabuchi 1995
  • In mice, rapamycin delayed the start of the hair cycle. Kellenberger 2013
  • In mice, rapamycin with metformin and alpha-ketoglutarate stimulated growth from rest through autophagy. Chai 2019
  • Dissolvable microneedles with rapamycin and EGCG nanoparticles regrew mouse hair faster than no treatment (untreated comparison only). Lin 2022
  • Rapamycin-primed stem-cell exosomes gave more follicles and density than unprimed ones in mice. Shrestha 2025
  • A meta-analysis of cancer-drug trials found targeted therapies as a group raise alopecia risk (RR 7.9 vs placebo, incidence 14.7%); an mTOR-specific figure was not extracted. Belum 2015
  • No human hair trial of rapamycin was found.

How it's used in studies

Topical, microneedle and exosome-priming protocols in mice only.

Side effects and safety

An immunosuppressant with serious infection, metabolic and wound-healing risks; avoid in pregnancy. Off-label "longevity" use is outside the evidence.

Bottom line

Mixed direction in animals and no human data. Do not use it for hair. Discuss with a doctor.

Fun facts

  • Three mouse studies give three different answers on whether rapamycin grows, delays or ignores hair cycling.

Studies 6

Iwabuchi T et al. Effects of PPIase inhibitors on hair growth initiation in mouse. J Dermatol Sci. 1995

Design
animal
Who
mice

Result: Cyclosporin A and FK506 induced anagen; rapamycin did not and blocked their effect.

Read the study ↗

Kellenberger AJ, Tauchi M. Mammalian target of rapamycin complex 1 (mTORC1) may modulate the timing of anagen entry in mouse hair follicles. Exp Dermatol. 2013

Design
animal
Who
mice

Result: Rapamycin delayed hair-cycle initiation.

Read the study ↗

Chai M et al. Stimulation of hair growth by small molecules that activate autophagy. Cell Rep. 2019

Design
animal
Who
mice

Result: Metformin, rapamycin and alpha-ketoglutarate started growth in resting follicles through autophagy; oral alpha-ketobutyrate prevented hair loss in aged mice.

Read the study ↗

Lin Y et al. Dissolvable microneedles loaded with rapamycin and EGCG nanoparticles for hair regrowth. Pharmaceutics. 2022

Design
animal
Who
mice

Result: Faster hair regrowth than no treatment (comparison was untreated).

Read the study ↗

Shrestha M et al. Rapamycin-primed MSC-derived exosomes. Theranostics. 2025

Design
animal
Who
mice

Result: Rapamycin-primed exosomes gave more follicles and density than naive exosomes.

Read the study ↗

Belum VR et al. Alopecia in patients treated with molecularly targeted anticancer therapies. Ann Oncol. 2015

Design
meta analysis
Who
many trials of targeted anticancer drugs

Result: Overall all-grade alopecia 14.7% (RR 7.9 vs placebo); vismodegib 56.9% (95% CI 50.5-63.1); bortezomib lowest at 2.2%.

Read the study ↗